Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

APUS stock hub

Apimeds Pharmaceuticals US, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

APUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

APUS

In the news

Latest news · APUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-78.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All APUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

108

Groups with data

Currency

USD

Showing 108 of 108 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001894525
Company name	Apimeds Pharmaceuticals US, Inc.
Country	United Arab Emirates
Country code	US
Cusip	03771D102
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2025-05-09
Isin	US03771D1028
Last refreshed	2026-05-10
Market cap	$19M
Market cap category	Nano-Cap
Price	$1.51
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	APUS
Website	https://www.mindwavedao.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
FCF yield	-27.55%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income Growth Years	0%
ROIC	-78.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Current Assets	$9.1M
Current Liabilities	$1.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	1.59
All Time High	5.97
All Time High Change	-74.65%
All Time High Date	2026-05-05
All Time Low	0.95
All Time Low Change	59.15%
All Time Low Date	2026-02-13
ATR	0.52
Beta1y	-0.73
Ch YTD	-7.71
High	1.59
High52	5.97
High52 Date	2026-05-05
High52ch	-74.65%
Low	1.4
Low52	0.95
Low52 Date	2026-02-13
Low52ch	59.15%
Ma50ch	-4.93%
Premarket Change Percent	6.9
Premarket Price	$1.55
Premarket Volume	24,758
RSI	46.49
RSI Monthly	0
RSI Weekly	45.39
Sharpe ratio	0.24x
Sortino ratio	0.4
Total Return	-29.09%
Tr YTD	-7.71
Tr1m	-19.49%
Tr1w	-49.55%
Tr3m	-6.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,544,233%
Float Percent	44.09%
Net Borrowing	250,100
Shares Insiders	4.89%
Shares Institutions	3.15%
Shares Out	12,575,983
Shares Qo Q	21.28%
Shares Yo Y	29.09%
Short Float	1.68%
Short Ratio	1.15
Short Shares	0.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.2M
Average Volume	413,552.4x
Ch1m	-19.49
Ch1w	-49.55
Ch3m	-6.57
Change	4.38%
Change From Open	0.23
Close	1.45
Days Gap	4.14
Depreciation Amortization	1,721
Dollar Volume	265,446.7
Earnings Date	2026-05-04
Earnings Time	bmo
F Score	0
FCF	$-5.2M
FCF Per Share	$-0.42
Fiscal Year End	December
Founded	2,020
Ipr	-62.16
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2025-09-30
Last Split Type	Never
Last10k Filing Date	2026-05-04
Ma20	1.8
Ma20ch	-16.1%
Next Earnings Date	2026-05-22
Open	1.51
Optionable	No
Position In Range	59.74
Ppne	34,188
Pre Close	1.45
Price Date	2026-05-08
Relative Volume	0.42x
Volume	175,386

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does APUS pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns APUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.1%

Float: +44.1% of shares outstanding

Insider ownership

+4.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

APUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About APUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current APUS stock rating?

Apimeds Pharmaceuticals US, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full APUS analysis?

The full report lives at /stocks/APUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for APUS?

The latest report frames APUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the APUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.